RxDoctor Payments Data

John Browning, MD

Emergency Medicine · Jackson, MSNPI 1396185765

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $436 and has fallen 66.9% since, to $144 in 2025. Among emergency medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,171in general payments, 2019–2025

Across 75 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$166
  • Novo Nordisk$129
  • Abbott$125
  • Amgen$112
  • GSK$88
  • Pfizer$73
  • plus $479 from 14 others

What the payments were for

  • Food & beverage$1,171100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,171 in reported general payments places this provider in the 95th percentile of 443 emergency medicine providers in Mississippi.

See all emergency medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$92,776
Medicare patients
515
Services billed
4,671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide122$2,477
Ondansetron OdtOndansetron32$1,706
PaxlovidNirmatrelvir/Ritonavir24$1,429
Fluticasone Propionate101$995
Albuterol Sulfate HfaAlbuterol Sulfate44$977
Methylprednisolone91$585
Oseltamivir Phosphate19$558
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav77$494
Clindamycin Hcl53$413
Doxycycline Hyclate57$403
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen88$382
Diclofenac Potassium12$319
Ketorolac Tromethamine21$318
Azelastine Hcl14$240
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst23$228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$73$1,42924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 emergency medicine providers in Mississippi.

Other emergency medicine in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →